Molecular biology of upper gastrointestinal malignancies

被引:58
作者
Lin, J [1 ]
Beer, DG [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Surg, Sect Gen Thorac Surg, Ann Arbor, MI 48109 USA
关键词
D O I
10.1053/j.seminoncol.2004.04.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While cancers of the upper gastrointestinal tract are related by location, they have distinct clinical and molecular characteristics. This review will focus on the molecular biology of esophageal adenocarcinoma (EAC) of which alterations in p53, overexpression of cyclin D1, loss of p16, and aneuploidy have been best characterized. Key similarities and differences, when compared to esophageal squamous cell carcinoma (ESCC), gastric adenocarcinoma (GC), and adenocarcinoma of the gastric cardia (AGC), will also be highlighted. Currently, malignancies of the upper gastrointestinal tract are often diagnosed at an advanced stage and are generally associated with a poor patient prognosis. With an improved understanding of the molecular biology of these tumors, there is hope that new targets for diagnosis, chemoprevention, and therapy will be developed. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:476 / 486
页数:11
相关论文
共 81 条
[51]  
2-N
[52]   Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets [J].
Reid, BJ ;
Levine, DS ;
Longton, G ;
Blount, PL ;
Rabinovitch, PS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07) :1669-1676
[53]  
REID BJ, 1992, GASTROENTEROLOGY, V102, P1212
[54]  
Riegman PHJ, 2001, CANCER RES, V61, P3164
[55]   EXPRESSION OF RAS ONCOGENE P21 PROTEIN IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA [J].
RUOL, A ;
STEPHENS, JK ;
MICHELASSI, F ;
SEGALIN, A ;
CHIARELLI, S ;
PERACCHIA, A ;
SKINNER, DB ;
LITTLE, AG .
JOURNAL OF SURGICAL ONCOLOGY, 1990, 44 (03) :142-145
[56]  
Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO
[57]  
2-U
[58]  
Sarbia M, 1999, CANCER, V86, P2597, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2597::AID-CNCR3>3.3.CO
[59]  
2-S
[60]  
Schrump DS, 1996, CANCER GENE THER, V3, P357